Michael Hotchkin

Michael Hotchkin is currently the Chief Business Officer at Clene Nanomedicine, Inc. Michael has a strong background in strategic operations and business development, with previous experience at AvantureBio LLC and Actelion. Michael's expertise spans from marketing research to district sales management, showcasing their extensive knowledge in the biopharmaceutical industry. Michael holds degrees in Political Science and Government, Medical Marketing, and Risk Modeling from Pepperdine University, UCLA Anderson School of Management, and Stanford University Graduate School of Business respectively.